Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial

Summary

Background: Gastric glitch is a new functional disease characterized by severe and transient epigastric pain occurring after challenges such as drinking alcohol and eating specific foods. Aims: In this N-of-1 trial, we first characterized the clinical and gastric tomographic images of a patient with gastric glitch highly reproducible after alcohol challenging, and then tested the effect of prucalopride and buspirone on the prevention of gastric glitch crises.

Timeline

Start

2022-01-06

Primary completion

2022-03-06

Completion

2022-03-06

Drugs

Indications